A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

BACKGROUND: Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options. METHODS: Using publicly available mRNA abundance datasets, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Syed, Wang, Jun, Nagano, Ai, Desai, Ami, Arumugam, Prabhu, Dumartin, Laurent, Fitzgibbon, Jude, Hagemann, Thorsten, Marshall, John F, Kocher, Hemant M, Crnogorac-Jurcevic, Tatjana, Scarpa, Aldo, Lemoine, Nicholas R, Chelala, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293116/
https://www.ncbi.nlm.nih.gov/pubmed/25587357
http://dx.doi.org/10.1186/s13073-014-0105-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293116/
https://www.ncbi.nlm.nih.gov/pubmed/25587357
http://dx.doi.org/10.1186/s13073-014-0105-3

Ejemplares similares